TABLE 2.
Comparing the laboratory characteristics between non-surviving groups and surviving groups.
| Parameter | 28-day | 90-day | 6-month | ||||||
|
|
|
|
|||||||
| Survivors | Non-survivors | P-value | Survivors | Non-survivors | P-value | Survivors | Non-survivors | P-value | |
| ALT, IU/L | 352 (93–856) | 452 (132–1190) | 0.133 | 352.0 (93–874) | 434.5 (118.8–1173) | 0.343 | 366.5 (93.5–948.5) | 362 (103–1117) | 0.910 |
| AST, IU/L | 210 (92–494.4) | 348 (167.0–966.6) | < 0.001 | 215 (92–494.4) | 293 (152–936.3) | 0.002 | 216.9 (92–515.5) | 274 (148.3–703) | 0.017 |
| Albumin, g/L | 33.3 (29.4–36.7) | 31.2 (28.7–33.3) | < 0.001 | 33.3 (29.4–36.6) | 31.4 (28.9–33.6) | < 0.001 | 33.4 (29.5–36.8) | 31.3 (28.7–33.7) | < 0.001 |
| Bilirubin, μmol/L | 192.5 (85.2–309.3) | 330.1 (220.5–424.4) | < 0.001 | 187.6 (83.6–300.3) | 328.1 (217.2–427.8) | < 0.001 | 189.9 (82.9–297.4) | 309.3 (200.8–424.4) | < 0.001 |
| ALP, IU/L | 151.4 (122–194) | 148 (121.0–194) | 0.943 | 151.4 (120–194) | 151 (122.3–194) | 0.709 | 151.4 (119.5–192.5) | 151.0 (122.3–203.5) | 0.525 |
| GGT, IU/L | 120 (72–186) | 978.0 (68–156.0) | 0.115 | 124 (74–188) | 95 (65–152) | 0.009 | 124.5 (76–190) | 91 (60.0–153.0) | 0.001 |
| Creatinine, μmol/L | 63.5 (53.8–76) | 68.3 (57.5–89.9) | < 0.001 | 63.5 (53.9–75.6) | 66.8 (53.9–89.9) | 0.051 | 63.6 (54.1–76.1) | 66.1 (53.0–87.4) | 0.168 |
| INR | 1.43 (1.21–1.76) | 2.15 (1.79–2.98) | < 0.001 | 1.41 (1.2–1.73) | 2.13 (1.75–2.97) | < 0.001 | 1.40 (1.18–1.70) | 2.12 (1.67–2.89) | < 0.001 |
| PT | 16.2 (13.9–19.5) | 23.9 (19.3–32.0) | < 0.001 | 16.1 (13.7–19.3) | 23.65 (19.1–31.9) | < 0.001 | 15.9 (13.6–18.95) | 23.5 (19.0–30.9) | < 0.001 |
| D-dimer | 0.95 (0.43–2.5) | 3.48 (1.42–5.11) | < 0.001 | 0.94 (0.42–2.43) | 3.13 (1.25–5.09) | < 0.001 | 0.92 (0.4–2.38) | 2.93 (1.18–5.03) | < 0.001 |
| Platelets, 10*9/L | 121 (85–168) | 89 (68–136) | < 0.001 | 124 (85–168) | 93 (66–138) | < 0.001 | 126 (87–173) | 93 (61–136) | < 0.001 |
| WBC, 10*9/L | 5.35 (4.11–7.21) | 6.67 (4.81–9.07) | < 0.001 | 5.33 (4.1–7.1) | 6.70 (4.85–9.37) | < 0.001 | 5.32 (4.07–7.07) | 6.62 (4.77–9.07) | < 0.001 |
| Na, mmol/L | 138.6 (136.5–140.6) | 136.9 (133.3–139.2) | < 0.001 | 138.6 (136.7–140.6) | 136.9 (133.0–139.1) | < 0.001 | 138.7 (136.8–140.7) | 137.1 (133.4–139.1) | < 0.001 |
| Child–Pugh score | 9 (7–11) | 12 (11–12) | < 0.001 | 9 (7–10) | 12 (11–12) | < 0.001 | 9 (7–10) | 12 (10–12) | < 0.001 |
| MELD score | 16 (12–20) | 24 (21–28) | < 0.001 | 15 (11–20) | 24 (21–27) | < 0.001 | 15 (11–19) | 23 (20–27) | < 0.001 |
| MELD-Na score | 16 (12–21) | 26 (21–30) | < 0.001 | 16 (12–21) | 25 (21–30) | < 0.001 | 16 (12–20) | 24 (21–30) | < 0.001 |
| NLR | 2.69 (1.79–4.39) | 5.43 (3.28–7.80) | < 0.001 | 2.64 (1.75–4.13) | 5.28 (3.28–7.67) | < 0.001 | 2.59 (1.73–4.1) | 4.93 (3.09–7.65) | < 0.001 |
| IL-6 | 7.78 (3.98–16.48) | 17.86 (8.54–30.09) | < 0.001 | 7.64 (3.98–15.53) | 16.73 (8.29–32.96) | < 0.001 | 7.705 (3.97–15.625) | 16.38 (7.44–32.81) | < 0.001 |
| LN (IL-6) | 2.05 (1.38–2.8) | 2.88 (2.14–3.67) | < 0.001 | 2.03 (1.38–2.74) | 2.82 (2.12–3.5) | < 0.001 | 2.05 (1.38–2.75) | 2.80 (2.01–3.49) | < 0.001 |
Bold values represent the statistically significant.